Regulation of antigen presentation by acidic pH

doi:10.1084/jem.171.5.1779

This Article

	Full Text (PDF, 374K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Jensen, P. E.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Jensen, P. E.


Social Bookmarking

	What's this?

ARTICLES

Regulation of antigen presentation by acidic pH

PE Jensen
Department of Pathology, Emory University School of Medicine, Atlanta, Georgia 30322.

The effect of pH on functional association of peptide antigens with APC membranes was investigated by using aldehyde-fixed B cells and class II- restricted T cell hybridomas to assess antigen/MHC complex formation. The results indicated that the rate and extent of functional peptide binding was markedly increased at pH 5.0 as compared with pH 7.3. The pH dependence of binding was preserved after pretreatment of fixed APC with pH 5.0 buffer, suggesting that pH had a direct effect on the interaction of peptide with the APC membrane. Similar results were obtained by using several peptides and I-Ad- and I-Ed-restricted T cells, indicating that pH may be of general importance in regulating the formation of functional antigen/class II MHC complexes.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Tobian, A. A. R., Canaday, D. H., Harding, C. V. (2004). Bacterial Heat Shock Proteins Enhance Class II MHC Antigen Processing and Presentation of Chaperoned Peptides to CD4+ T Cells. J. Immunol. 173: 5130-5137 [Abstract] [Full Text]
Carven, G. J., Chitta, S., Hilgert, I., Rushe, M. M., Baggio, R. F., Palmer, M., Arenas, J. E., Strominger, J. L., Horejsi, V., Santambrogio, L., Stern, L. J. (2004). Monoclonal Antibodies Specific for the Empty Conformation of HLA-DR1 Reveal Aspects of the Conformational Change Associated with Peptide Binding. J. Biol. Chem. 279: 16561-16570 [Abstract] [Full Text]
Sinnathamby, G., Eisenlohr, L. C. (2003). Presentation by Recycling MHC Class II Molecules of an Influenza Hemagglutinin-Derived Epitope That Is Revealed in the Early Endosome by Acidification. J. Immunol. 170: 3504-3513 [Abstract] [Full Text]
Ullrich, H.-J., Beatty, W. L., Russell, D. G. (2000). Interaction of Mycobacterium avium-Containing Phagosomes with the Antigen Presentation Pathway. J. Immunol. 165: 6073-6080 [Abstract] [Full Text]
Nanda, N. K., Sant, A. J. (2000). Dm Determines the Cryptic and Immunodominant Fate of T Cell Epitopes. JEM 192: 781-788 [Abstract] [Full Text]
Chervonsky, A. V., Medzhitov, R. M., Denzin, L. K., Barlow, A. K., Rudensky, A. Yu., Janeway, C. A. Jr. (1998). Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides. Proc. Natl. Acad. Sci. USA 95: 10094-10099 [Abstract] [Full Text]
Fridkis-Hareli, M., Strominger, J. L. (1998). Promiscuous Binding of Synthetic Copolymer 1 to Purified HLA-DR Molecules. J. Immunol. 160: 4386-4397 [Abstract] [Full Text]
Gapin, L., Bravo de Alba, Y., Casrouge, A., Cabaniols, J. P., Kourilsky, P., Kanellopoulos, J. (1998). Antigen Presentation by Dendritic Cells Focuses T Cell Responses Against Immunodominant Peptides: Studies in the Hen Egg-White Lysozyme (HEL) Model1. J. Immunol. 160: 1555-1564 [Abstract] [Full Text]
Reich, Z., Altman, J. D., Boniface, J. J., Lyons, D. S., Kozono, H., Ogg, G., Morgan, C., Davis, M. M. (1997). Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: Comparison to class�I�proteins. Proc. Natl. Acad. Sci. USA 94: 2495-2500 [Abstract] [Full Text]
Fox, R. (1996). Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development. Lupus 5: S4-S10 [Abstract]